Avinger, Inc. (AVGR)

NASDAQ: AVGR · IEX Real-Time Price · USD
+0.100 (2.90%)
Feb 26, 2024, 12:12 PM EST - Market open

Avinger Revenue

Avinger had revenue of $7.75M in the twelve months ending September 30, 2023, down -10.70% year-over-year. Revenue in the quarter ending September 30, 2023 was $1.82M, a -19.32% decrease year-over-year. In the year 2022, Avinger had annual revenue of $8.27M, a decrease of -18.33%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
4.38M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20228.27M-1.86M-18.33%
Dec 31, 202110.13M1.37M15.63%
Dec 31, 20208.76M-370.00K-4.05%
Dec 31, 20199.13M1.22M15.36%
Dec 31, 20187.92M-2.02M-20.32%
Dec 31, 20179.93M-9.28M-48.30%
Dec 31, 201619.21M8.50M79.35%
Dec 31, 201510.71M-500.00K-4.46%
Dec 31, 201411.21M-1.75M-13.51%
Dec 31, 201312.96M4.40M51.45%
Dec 31, 20128.56M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IM Cannabis 58.54M
iSpecimen 10.31M
OpGen 3.07M
Aethlon Medical 574.25K
iBio, Inc. 50.00K
Revenue Rankings